Portfolio Highlights
The Trendlines Group invests in innovations in agrifood technologies and medtech, leveraging our experience, network, and resources to go from seed to market
High-quality natural food colors derived from first-in-class baker’s yeast fermentation technology. Phytolon’s high-quality and cost-effective pigments offer value for consumers, the environment, and the food industry.
Achievements
- Full POC: color production and application in food products
- Commercial agreement with DSM
- Successful pilots with industry leaders, including Nestlé
- R&D collaboration agreement with Ginkgo Bioworks
Minimally invasive, nonsurgical, incision-free, and mesh-free repair device to treat pelvic organ prolapse (POP) allowing early-stage treatment and significantly improving the quality of life for millions of women globally.
Achievements
- FDA clearance
- Successful completion and follow-up on the FIW clinical study
- Initial commercialization of Escala’s MenditTM product in the US
AgroScout collects and integrates data from multiple sources (field, air, space) and scientifically analyzes them to produce detection and recognition reports that supply actionable insights of agribio risks and sustainability monitoring.
Achievements
- 2022: launched global sales, with leading partners such as PepsiCo
- Partnering with global players: Kraft Heinze, Mondelez, Adama, Pepsico, DJI, AECI
- Providing service on multiple crops
A new ablative approach for the treatment of non-muscle invasive bladder cancer
Achievements
- Investment with strategic partner and VC participation
- Ongoing clinical study showing positive results in treatment of urological tissue
Exits
Expanding treatment options for adolescent idiopathic scoliosis
In 2020, ApiFix was acquired and became a wholly owned subsidiary of OrthoPediatrics Corp. (Nasdaq: KIDS), focused exclusively on advancing the field of pediatric orthopedics and improving the lives of children with orthopedic conditions.
Robotic external fixation system
OrthoSpin was acquired by Synthes GMBH (part of DePuy Synthes, the Orthopaedics company of Johnson & Johnson) in November 2021.
Invest in Success
The Trendlines Group invests in innovations in agrifood and healthcare, leveraging our experience, network, and resources to go from seed to market.
News
16 March 2026
Seger Surgical Solutions Achieves Milestone with Successful Human Trials of Laparoscopic Bowel Closure Device
Three Successful First-in-Human Cases Completed in El Salvador
10 March 2026
IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides
POC included in vivo insect validation of de novo designed proteins
17 February 2026
Arcuro Medical Significantly Expands SuperBall® Market Opportunity with New Rotator Cuff Repair System; Launches Newly-Enhanced Meniscus Repair System
New indications and enhancements target a potential $1.1 billion addressable market by...
9 February 2026
Phytolon Achieves Major FDA Regulatory Milestone Paving the Way for Commercialization
The FDA approval paves the way for U.S. commercialization and uses across...
Contact
Israel
17 T’chelet Street M.P. Misgav, 2017400
Singapore
1 Pasir Panjang Road, #30-01, Labrador Tower, Singapore 118479
